Look Past Hype: The Cold Cash Metric Picks One Buy
Salesforce and Palantir posted strong quarters, but the market rewards or punishes them based on cash-return potentia...
Stock indices serve as market barometers, benchmarks, and investment guides. Learn how they inform decisions and performance tracking.
17,462 articlesSalesforce and Palantir posted strong quarters, but the market rewards or punishes them based on cash-return potentia...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
Oracle’s stock has fallen from its AI-redemption peak as management bets heavily on data-center compute. Analysts are...
As AI models scale, memory bandwidth becomes the bottleneck. This article digs into Nvidia's role in HBM4, the chatte...
Pediatrix (MD) 2025 earnings shaped a cautious optimism about growth and margins in a competitive pediatric care mark...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
A practical, investor-focused look at delcath (dcth) 2025 earnings prospects. We break down the catalysts, risks, and...
First Solar has been delivering profits, but a heavy reliance on subsidies creates real investment risk. This article...
Biotech giants 2026 could offer a compelling mix of growth and stability for investors. This article dives into two p...